Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (814)	7/24/2003 2:02:48 PM
From: tuck	Read Replies (2) \| Respond to of 1005

The IPO window opens! Sort of. This looks a little fishy: >>NEW YORK, July 24 /PRNewswire/ -- Diversified Biotech Holdings Corp. (DBHC) announced today that it had filed a registration statement on Form SB-2 on July 21, 2003 with the Securities and Exchange Commission for a proposed initial public offering of 2,500,000 shares of common stock, at an estimated initial public offering price of between $4.00 and $6.00 per share. DBHC intends to apply to have its common stock approved for listing on the American Stock Exchange. DBHC intends to use the proceeds from the offering for acquisitions, marketing, expansion, investment and operating expenses. DBHC's wholly-owned subsidiary, InvestPrivate, Inc., will participate in this offering as an underwriter. In addition, The Shemano Group has been engaged to act as a co-manager and as the Qualified Independent Underwriter for the purpose of recommending the maximum offering price. A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet been declared effective. These securities may not be sold, nor may offers to buy be accepted prior to the time the registration becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any state. When available, a copy of the written preliminary prospectus relating to the offering may be obtained from DBHC, 500 Fifth Avenue, 56th floor, New York, NY 10110. About Diversified Biotech Holdings Corp.: Diversified Biotech Holdings Corp. (DBHC) is a diversified organization that seeks to help investors and its customers capitalize on business and investment opportunities in the biotechnology sector. DBHC is the holding company for InvestPrivate, Inc., a broker-dealer, and InvestBio, Inc., a suite of investment and informational products for biotech investors and biotech professionals. DBHC was established to create opportunities for its shareholders, clients and employees by taking advantage of the biotechnology sector. DBHC is headquartered at 500 Fifth Avenue, 56th Floor, New York, NY 10110. The Company's telephone and fax numbers are 212.739.7700 and 212.655.3681, respectively. Its website is www.investbio.com (InvestPrivate: www.investprivate.com).<< snip Cheers, Tuck

To: Biomaven who wrote (814)	1/27/2004 12:47:28 PM
From: tuck	Read Replies (2) \| Respond to of 1005

POZN hasn't even announced any actual data, but the stock is up smartly on a tough day . . . >>CHAPEL HILL, N.C.--(BUSINESS WIRE)--Jan. 27, 2004--POZEN Inc. (Nasdaq:POZN - News) announced today that it will host a webcast on Wednesday, January 28, 2004 at 8:30 a.m. Eastern Time to discuss the results of a two-year rat carcinogenicity study for MT 100. A news release about the results of the study will be issued the same morning prior to the webcast. The webcast will be live and available for replay on POZEN's website at www.pozen.com. MT 100 is being developed as an oral first-line therapy for the treatment of migraine. << snip Makes one wonder if one of the rats talked to an Avalon analyst who sneaked into their cage in a rat costume: "I'm still here, there are no lumps, and I feel great." Cheers, Tuck